Jasper Therapeutics JSPR
NASDAQ JSPR
$0.51 +0.01 (+2.00%)
As of: Oct 21, 2026 · 3:50 PM EDT

Jasper Therapeutics (JSPR) Intangibles (2021)

Updated

Jasper Therapeutics (JSPR) reported Intangibles of $5 million for Q2 2021.

Analysis

Jasper Therapeutics (JSPR) Intangibles (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,138.83 Bn 1,107.41 Bn 19.71 Bn 18.11 Bn
2 Johnson & Johnson 618.88 Bn 537.41 Bn 17.26 Bn 48.23 Bn
3 AbbVie 502.93 Bn 476.04 Bn 12.70 Bn 49.14 Bn
4 Merck 369.61 Bn 323.99 Bn 12.21 Bn 24.98 Bn
5 Novartis Ag 298.70 Bn 262.69 Bn 11.24 Bn 42.07 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 37.72 Bn
7 Amgen 237.59 Bn 192.99 Bn 7.24 Bn 20.49 Bn
8 Gilead Sciences 191.60 Bn 165.79 Bn 6.22 Bn 14.03 Bn
9 Pfizer 170.23 Bn 116.88 Bn 10.94 Bn 47.05 Bn
10 Jasper Therapeutics 14.63 Mn -111.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 5.00 Mn
API Access

Jasper Therapeutics Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=JSPR&period=max&api_key=YOUR_API_KEY